Digital health means different things to different people, but what does it mean to Big Pharma? Where are their efforts focused?
There are many forces shaping healthcare Innovation including governments, tech (big and small), payers, and consumers. Improvements are needed to meet the goals of prevention, enhanced discovery, cost reduction, greater access and adherence. Improving outcomes requires innovation in all these areas. Considering this wide definition of Health Tech, where are the pharmaceutical arms of large pharma putting investment resources.
We gathered a unique set of professionals who are tasked with shaping the future of Health and Technology for a look inside the challenges and opportunities of improving healthcare with technology.
Key Topics include:
· What areas of the patient journey will most likely be affected by digital health technology?
o Where are you focused in the short and long term?
o What are the biggest opportunities / challenges to meeting your goals?
· The effect of Big Tech involvement in Healthcare
· Cost reduction and clinical trial improvements
· Speeding access to care and medication
· Prevention and fully digital treatments
· Changing regulations and payor models
· Consumer expectations and wearables
· Regulations and uncertainty
· Improving drug discovery and R&D productivity
· RWE-based value demonstration/outcome based care
· Novel endpoints (digital biomarkers)